Safety and Efficacy Study Using Rexin-G for Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: GENETIC: Rexin-G
Sponsor: Epeius Biotechnologies